Verve Therapeutics Inc.

NASDAQ: VERV · Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM

Verve Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-181.01M -198.71M -197.03M -192.65M -196.83M -200.07M -192.8M -192.23M -179.2M -157.39M -147.64M -125.2M -137.22M -120.31M -112.51M -98.75M -53.36M
Depreciation & Amortization
6.84M 6.75M 6.57M 6.29M 5.96M 5.46M 4.86M 4.11M 3.42M 2.8M 2.35M 2.05M 1.75M 1.53M 1.32M 1.53M 1.46M
Stock-Based Compensation
44.09M 43.26M 42.06M 40.07M 37.43M 35.12M 32.57M 29.66M 26.3M 22.48M 18.53M 14.9M 10.61M 7.07M 4.76M 2.68M 1.43M
Other Working Capital
-14.2M -3.07M -4.3M 22.94M 20.46M 19.88M 25.88M 7.91M 14.62M 13.6M 8.02M -6.71M -8.05M -9.74M -2.27M 2.45M 32K
Other Non-Cash Items
-4.7M -6.73M 3.07M 4.91M 10.68M 10M -2.38M 1.17M -1.12M 1.39M 3.44M -382K 35.56M 35.23M 41.8M 41.21M 6.15M
Deferred Income Tax
n/a n/a -10.56M -14.06M -17.75M -17.75M -7.19M -3.7M n/a n/a 740K 1.15M 1.3M 1.51M 947K 670K 582K
Change in Working Capital
-7.67M -2.26M -1.63M 25.71M 16.97M 17.7M 23.18M 1.87M 12.68M 8.38M 5.09M -2.19M -8.25M -2.91M -1.13M 2.88M 166K
Operating Cash Flow
-142.46M -157.69M -157.53M -129.73M -143.53M -149.55M -141.76M -159.13M -137.92M -122.33M -117.48M -109.66M -96.25M -77.88M -64.81M -49.78M -43.58M
Capital Expenditures
-4.53M -3.74M -4.53M -4.66M -6.34M -9.28M -12.07M -13.64M -13.7M -13.23M -9.24M -7.61M -6.2M -4.36M -4.33M -4.35M -3.44M
Cash Acquisitions
n/a n/a 6.71M 17.48M -18.21M -36.97M 119.66M 161.77M 186.96M 205.72M 42.38M -10.5M n/a n/a n/a n/a n/a
Purchase of Investments
-404.62M -424M -473.25M -546.36M -547.58M -517.14M -652.14M -652.03M -613.16M -479.4M -359.08M -434.57M -360.32M -371.49M -244.65M -36.53M -109.66M
Sales Maturities Of Investments
477.49M 502.61M 514.22M 518.81M 524.58M 554.11M 532.48M 490.26M 426.2M 336.68M 323.7M 240.75M 175.79M 136.75M 78.75M 80.25M 65.05M
Other Investing Acitivies
n/a n/a -6.71M -17.48M 18.21M 36.97M -119.66M -161.77M -186.96M -142.72M -35.38M -193.82M -184.52M -234.74M -165.9M 43.72M -44.61M
Investing Cash Flow
68.34M 74.88M 36.44M -32.21M -29.33M 27.69M -131.73M -175.41M -200.66M -155.96M -44.63M -201.43M -190.72M -239.1M -170.23M 39.37M -48.05M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.22M 2.46M 2.24M 2.44M 2.32M 2.12M 2.5M 2.79M 2.01M 2.46M 2.68M 1.31M 283.76M 283.33M 282.11M 282.98M 80K
Financial Cash Flow
26.47M 49.2M 201.43M 233.34M 233.27M 212.58M 74.79M 331.28M 330.49M 328.96M 290.58M 1.31M 283.76M 377.09M 375.87M 376.74M 156.73M
Net Cash Flow
-47.65M -33.62M 80.34M 71.4M 60.4M 90.72M -198.7M -3.26M -8.09M 50.67M 128.47M -309.78M -3.2M 60.11M 140.84M 366.33M 65.09M
Free Cash Flow
-146.98M -161.43M -162.06M -134.39M -149.88M -158.83M -153.83M -172.77M -151.62M -135.56M -126.73M -117.27M -102.44M -82.24M -69.14M -54.13M -47.02M